(Q45367150)

13 December 2017

Shedding of Ann Arbor strain live attenuated influenza vaccine virus in children 6-59 months of age. (English)

1 reference

13 December 2017

1 reference

1 reference

Christopher S Ambrose

series ordinal

3

1 reference

13 December 2017

Raburn M Mallory

1

1 reference

PubMed ID

21513761

13 December 2017

Tingting Yi

series ordinal

2

1 reference

PubMed ID

21513761

13 December 2017

language of work or name

English

0 references

publication date

20 April 2011

1 reference

13 December 2017

1 reference

13 December 2017

29

1 reference

13 December 2017

26

1 reference

13 December 2017

4322-4327

1 reference

Plaque formation of influenza virus at 25 degrees C.

13 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.04.022

Evaluation of a cold-recombinant influenza virus vaccine in ferrets

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.04.022

Duration of virus shedding after trivalent intranasal live attenuated influenza vaccination in adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.04.022

Principles underlying the development and use of live attenuated cold-adapted influenza A and B virus vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.04.022

Shedding and immunogenicity of live attenuated influenza vaccine virus in subjects 5-49 years of age.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.04.022

A randomized, double-blind study of the safety, transmissibility and phenotypic and genotypic stability of cold-adapted influenza virus vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.04.022

Safety and immunogenicity of live attenuated cold-adapted influenza B/Ann Arbor/1/86 reassortant virus vaccine in infants and children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.04.022

Comparison of live, attenuated H1N1 and H3N2 cold-adapted and avian-human influenza A reassortant viruses and inactivated virus vaccine in adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.04.022

Live attenuated versus inactivated influenza vaccine in infants and young children.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.04.022

The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenzavirus vaccine in children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.04.022

Safety of the trivalent, cold-adapted influenza vaccine in preschool-aged children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.04.022

Prospective, randomized, placebo-controlled evaluation of the safety and immunogenicity of three lots of intranasal trivalent influenza vaccine among young children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.04.022

Evaluation of a cold-adapted influenza B/Texas/84 reassortant virus (CRB-87) vaccine in young children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.04.022

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VACCINE.2011.04.022

1 reference

13 December 2017

1 reference

PubMed ID

21513761